Who is sponsoring NCT04414423?

NCT04414423 is sponsored by Fayoum University.

What condition does NCT04414423 study?

NCT04414423 studies Alveolar Cleft Grafting.

Is NCT04414423 still recruiting?

NCT04414423 is currently completed. Last updated 7 December 2021.

Last reviewed 2021-12-07 · How we verify

NCT04414423

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combination of Bone Marrow Concentrate and Iliac Cancellous Bone Graft in Alveolar Cleft Grafting

Completed NA Last updated 7 December 2021

What this trial tests

NA trial testing bone marrow concentrate alveolar cleft grafting in Alveolar Cleft Grafting in 18 participants. Completed in 1 December 2021.

Timeline

1 November 2020

Primary endpoint
20 November 2021

1 December 2021

Quick facts

Lead sponsor	Fayoum University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	18
Start date	1 November 2020
Primary completion	20 November 2021
Estimated completion	1 December 2021
Sites	2 locations across Egypt

Drugs / interventions tested

bone marrow concentrate alveolar cleft grafting
Autogenous alveolar grafting

Conditions studied

Alveolar Cleft Grafting — all drugs for Alveolar Cleft Grafting →

Sponsor

Fayoum University

Who can join

Adults 8 to 12, any sex, with Alveolar Cleft Grafting. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study will be to analyze the newly formed bone volume and density, 6 months after alveolar cleft grafting using iliac cancellous bone graft, with and without bone marrow concentrate.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Alveolar cleft reconstruction using bone marrow aspirate concentrate and iliac cancellous bone: A 12-month randomized clinical study.
Shabaan AA, Salahuddin A, Aboulmagd I, Ragab R, et al · · 2023 · cited 5× · PMID 37794139 · DOI 10.1007/s00784-023-05276-9

Verify or expand the search:

Other recruiting trials for Alveolar Cleft Grafting

Currently open trials in the same condition.

NCT07137975 — Assessment of Bone Volume Using Patient Specific Autogenous Bone Plug Versus Particulate Autogenous Bone for Unilateral · NA · active not recruiting

Other Fayoum University trials

Trials by the same sponsor.

NCT07536620 — Metformin and Alveolar Cleft · Phase 2 · not yet recruiting
NCT07444970 — Comparative Evaluation of Xenograft Alone and Sticky Bone in Sinus Lift With Concurrent Implant Placement · NA · not yet recruiting
NCT07394179 — Transforming Channel Osteotomy Into Tunnel Osteotomy in Zygomatic Implant Preparation · NA · not yet recruiting
NCT07277348 — Analysis of The Outcomes of Therapeutic Photorefractive Keratectomy Combined With Prophylactic Accelerated Cross-Linking · NA · not yet recruiting
NCT07330726 — Lidocaine Patch and Lower Third Molar · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04414423 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fayoum University
Last refreshed: 7 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04414423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing